Steven A. Kriegsman, Director at RXI PHARMACEUTICALS CORP (RXII), sold 2,893 shares at $4.19 ($13K) on 2009-07-02, disclosed to the SEC on 2009-07-06.
Scheduled sale ($13k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.53 | 1,170 | $5K | 42.3% |
| 2 | $4.19 | 1,723 | $7K | 57.7% |
| Total | $4.33 avg | 2,893 | $13K | 100% |
| Filing → |
| CYTR | BUY | 2012-02-24 | $51K | — | Filing → |
| RXII | SELL | 2009-08-20 | $28K | — | Filing → |
| RXII | SELL | 2009-07-01 | $21K | — | Filing → |